Resultados: 9

    AGA clinical practice update on the diagnosis and management of Atrophic Gastritis: expert review

    Gastroenterology; 161 (4), 2021
    The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis due to chronic Helicobacter pylori infection-the most common...

    WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2nd ed

    Cervical cancer is a leading cause of mortality among women. In 2020, an estimated 604 000 women were diagnosed with cervical cancer worldwide and about 342 000 women died from the disease. Cervical cancer is the most commonly diagnosed cancer in 23 countries and is the leading cause of cancer death in 3...

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and to support countries to update their national guidelines for the use of thermal ablation for cervical precancer....

    WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions

    The objectives of these guidelines are: • to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and • to support countries to update their national guidelines for the use of thermal ablation for cervical precancer. These guidelines were developed using the W...

    British Society of Gastroenterology position statement on serrated polyps in the colon and rectum

    Gut; 66 (7), 2017
    Serrated polyps have been recognised in the last decade as important premalignant lesions accounting for between 15% and 30% of colorectal cancers. There is therefore a clinical need for guidance on how to manage these lesions; however, the evidence base is limited. A working group was commission by the ...

    Clinical practice guidelines on the screening and treatment of precancerous lesions for cervical cancer prevention in Saudi Arabia

    Ann. Saudi med; 36 (5), 2016
    BACKGROUND: Cervical cancer is the third most common gynecological malignancy in Saudi women with an estimated incidence rate of 1.9 cases per 100 000 women-years. More than 40% of cervical cancer cases are diagnosed at advanced stages due to lack of a routine screening program in Saudi Arabia. Thus, nat...

    World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer

    Int. j. gynaecol. obstet; 132 (2), 2016
    "BACKGROUND: It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. If left untreated, CIN 2-3 can progress to cervical cancer. WHO has previously published guidelines for strateg...

    Guía de Práctica Clínica ​(GPC) para la detección y manejo de lesiones precancerosas de cuello uterino

    Definir la(s) prueba(s) diagnóstica(s) que se deben utilizar para la tamización de lesiones precancerosas de cuello uterino en mujeres que hayan iniciado vida sexual y en mujeres con histerectomía previa por patología no maligna, determinando intervalos, edades y la estrategia de clasificación diagn...

    WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention

    Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to cervical cancer. Instead of screening and diagnosis by the standard sequence of cytology, c...